Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders
- PMID: 24791199
- PMCID: PMC4006340
- DOI: 10.12865/CHSJ.40.01.02
Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders
Abstract
Obesity and metabolic syndrome in association with an increased risk of cardiovascular disease and type II diabetes are significant problems that contribute to lower life expectancy of patients with schizophrenia. Understanding the pharmacological mechanisms of the current antipsychotic treatment is clearly the key to the improvement of pharmacotherapy, to avoid or to mitigate the metabolic adverse effects.
Keywords: antipsychotic; metabolic disorders; pharmacological mechanisms.
Similar articles
-
Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.Pharmacol Ther. 2010 Jan;125(1):169-79. doi: 10.1016/j.pharmthera.2009.10.010. Epub 2009 Nov 17. Pharmacol Ther. 2010. PMID: 19931306 Review.
-
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. Encephale. 2009. PMID: 19748369 French.
-
[Schizophrenia, diabetes mellitus and antipsychotics].Encephale. 2004 Jul-Aug;30(4):382-91. doi: 10.1016/s0013-7006(04)95452-8. Encephale. 2004. PMID: 15538314 Review. French.
-
[Metabolic side effects of risperidone in early onset schizophrenia].Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. Encephale. 2010. PMID: 20620267 French.
-
[Metabolic syndrome induced by antipsychotic drugs. The problem of obesity].Vertex. 2008 Nov-Dec;19(82):338-47. Vertex. 2008. PMID: 19424516 Spanish.
Cited by
-
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?Lipids Health Dis. 2020 Feb 7;19(1):22. doi: 10.1186/s12944-020-01203-z. Lipids Health Dis. 2020. PMID: 32033608 Free PMC article. Review.
-
Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal.Ann Gen Psychiatry. 2021 Dec 13;20(1):52. doi: 10.1186/s12991-021-00374-y. Ann Gen Psychiatry. 2021. PMID: 34903254 Free PMC article.
-
Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Front Psychiatry. 2014 Sep 26;5:137. doi: 10.3389/fpsyt.2014.00137. eCollection 2014. Front Psychiatry. 2014. PMID: 25309466 Free PMC article. Review.
-
Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study.Eur J Clin Pharmacol. 2017 Feb;73(2):233-239. doi: 10.1007/s00228-016-2158-2. Epub 2016 Nov 24. Eur J Clin Pharmacol. 2017. PMID: 27885398
-
Inter-relationships of risk factors and pathways associated with all-cause mortality in patients with chronic schizophrenia.Front Psychiatry. 2024 May 20;14:1309822. doi: 10.3389/fpsyt.2023.1309822. eCollection 2023. Front Psychiatry. 2024. PMID: 38831863 Free PMC article.
References
-
- Van Os J, Kapur S. Schizophrenia. Lancet. 2009;374:635–645. - PubMed
-
- Castle D, Wessely S, Der G, Murray RM. The incidence of operationally defined schizophrenia in Camberwell, 1965-84. The British Journal of Psychiatry. 1991;159:790–794. - PubMed
-
- Kumra S, Shaw M, Merka P, Nakayama E, Augustin R. Childhood-onset schizophrenia: research update. Canadian Journal of Psychiatry. 2001;46(10):923–930. - PubMed
-
- McGurk SR, Mueser KT, Feldman K, et al. Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial. American Journal of Psychiatry. 2007;164(3):437–441. - PubMed
Publication types
LinkOut - more resources
Full Text Sources